This monoclonal antibody can bind to BSG2 and inhibit various BSG2 functions, which is useful for treating and diagnosing a variety of diseases, such as cancers associated with BSG2 mediated angiogenesis.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-1291CL | Anti-Human BSG2 Recombinant Antibody (6A11-3A3) | ELISA, Inhib | |
TAB-1292CL | Anti-Human BSG2 Recombinant Antibody (1F4-2C1) | FC, FuncS | |
TAB-1291CL-S(P) | Anti-Human BSG2 Recombinant Antibody scFv Fragment (6A11-3A3) | ELISA, Inhib | |
TAB-1292CL-S(P) | Anti-Human BSG2 Recombinant Antibody scFv Fragment (1F4-2C1) | FC, FuncS | |
TAB-1293CL-S(P) | Anti-Human BSG2 Recombinant Antibody scFv Fragment (2D2-2A1) | FC, FuncS |
There are currently no Customer reviews or questions for TAB-1293CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.